Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

Recent & Breaking News (TSX:EDT)

Spectral Medical Announces Report on Clinical Implementation of SAMI Amid COVID-19 Published in the Journal of Blood Purification

GlobeNewswire November 11, 2020

Spectral and Dialco Sponsored Symposiums at the 38th Vicenza Course on AKI and CRRT

GlobeNewswire November 3, 2020

Spectral to Present at H.C. Wainwright & Co. 22nd Annual Global Investment Conference

GlobeNewswire September 8, 2020

U.S. FDA Grants 510(k) Clearance for Spectral's DIMI

GlobeNewswire August 31, 2020

Spectral Announces Second Quarter Results

GlobeNewswire August 14, 2020

US FDA Approves Spectral Medical's Protocol Amendment for TIGRIS

GlobeNewswire August 10, 2020

Spectral Medical Provides Corporate Update

GlobeNewswire August 5, 2020

Spectral Medical Inc. Appoints John E. Nosenzo to its Board of Directors

GlobeNewswire August 4, 2020

Spectral Medical Inc. Files Base Shelf Prospectus

GlobeNewswire July 6, 2020

Spectral Medical Inc. Files Preliminary Base Shelf Prospectus

GlobeNewswire June 26, 2020

Spectral Medical Inc. Closes Previously Announced $5.1 Million Public Offering of Units

GlobeNewswire June 18, 2020

The Top Healthcare Bullboards: April - June 2020

Stockhouse Editorial June 17, 2020

Spectral Announces Voting Results of Annual General and Special Meeting and Promotion of Chris Seto to Chief Operating Officer

GlobeNewswire June 5, 2020

Spectral Medical Inc. Announces Proposed Public Offering of Units

GlobeNewswire May 27, 2020

Spectral Announces First Quarter Results

GlobeNewswire May 15, 2020

Spectral Medical Provides Corporate Update

GlobeNewswire April 28, 2020

Health Canada Issues an Interim Order for Spectral Medical's PMX to Treat COVID-19 Patients

GlobeNewswire April 20, 2020

US FDA Approves an Investigational Device Exemption for Spectral Medical PMX to Treat COVID-19 Patients Suffering from Septic Shock

GlobeNewswire April 14, 2020

Spectral Provides Update on the Commercial Development of its SAMI Device for Continuous Renal Replacement Therapy

GlobeNewswire April 2, 2020

SPECTRAL ANNOUNCES FOURTH QUARTER AND FISCAL 2019 RESULTS

GlobeNewswire March 27, 2020